Search

Your search keyword '"Blood Coagulation Disorders drug therapy"' showing total 1,965 results

Search Constraints

Start Over You searched for: Descriptor "Blood Coagulation Disorders drug therapy" Remove constraint Descriptor: "Blood Coagulation Disorders drug therapy"
1,965 results on '"Blood Coagulation Disorders drug therapy"'

Search Results

1. Efficacy of unfractionated heparin in patients with moderate sepsis-induced coagulopathy: An observational study.

2. The changes of coagulation profiles in Kawasaki disease and its associations with clinical classification, intravenous immunoglobulin responsiveness and coronary artery involvement.

4. Association between the use of statins and in-hospital mortality risk in patients with sepsis-induced coagulopathy during ICU stays: a study based on medical information mart for intensive care database.

5. Improving 1-Deamino-8-D-Arginine Vasopressin (DDAVP) Challenges in Pediatric/Young Adult Patients With Bleeding Disorders: A Quality Improvement Study.

6. A Rare Cause of Coagulopathy in the Emergency Department: Cefoperazone Use.

7. COMPREHENSIVE THERAPEUTIC EFFICACY ANALYSIS OF INTRAVENOUS IMMUNOGLOBULIN IN TREATING SEPSIS-INDUCED COAGULOPATHY: A SINGLE-CENTER, RETROSPECTIVE OBSERVATIONAL STUDY.

8. Abnormalities of Coagulation and Fibrinolysis Assessed by Thromboelastometry in an Endotoxic Shock Model in Piglets Treated with Nitric Oxide and Hydrocortisone.

9. Trauma coagulopathy: Insights from the PROCOAG and CRYOSTAT-2 trials. Coagulation factors are not antibiotics.

10. Ruthenium-based antivenom attenuates Crotalus atrox venom mediated coagulopathy in rabbits.

11. Use of crushed tranexamic acid tablets in water for paediatric patients with bleeding disorders.

12. Intramuscular administration of tranexamic acid in a large swine model of hemorrhage with hyperfibrinolysis.

13. Rare bleeding disorders: Advances in management.

14. Special Issue "COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies".

15. Rapid clearing CT-001 restored hemostasis in mice with coagulopathy induced by activated protein C.

16. Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years.

17. Efficacy and safety of heparin for sepsis-induced disseminated intravascular coagulation (HepSIC): study protocol for a multicenter randomized controlled trial.

18. Analysis of fibrinolytic shutdown in trauma patients with traumatic brain injury.

20. The use of vitamin K for coagulopathy in critically ill children.

21. [Assessment of a therapeutic protocol for the management of snakebite envenomations in Benin].

23. Viscoelastic coagulation testing in Neonatal Intensive Care Units: advantages and pitfalls in clinical practice.

24. Prothrombin complex concentrate (PCC) for treatment of trauma-induced coagulopathy: systematic review and meta-analyses.

25. The Crosstalk between Nephropathy and Coagulation Disorder: Pathogenesis, Treatment, and Dilemmas.

26. High prevalence of heavy menstrual bleeding in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study.

27. Novel Toxicodynamic Model of Subcutaneous Envenomation to Characterize Snake Venom Coagulopathies and Assess the Efficacy of Site-Directed Inorganic Antivenoms.

28. The prevalence and risk factors of coagulopathy in pediatric patients undergoing surgery for epilepsy.

29. Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis.

30. Bleeding management in patients with direct oral anticoagulants.

31. A review of 95 pit viper envenomations in Northcentral Florida (2018-2020).

32. Endothelial glycocalyx injury is involved in heatstroke-associated coagulopathy and protected by N-acetylcysteine.

33. Effectiveness of Administration of Fibrinogen Concentrate as Prevention of Hypofibrinogenemia in Patients with Traumatic Brain Injury with a Higher Risk for Severe Hyperfibrinolysis: Single Center Before-and-After Study.

34. An outbreak of severe coagulopathy in northern Israel among users of illicit synthetic cannabinoids adulterated with brodifacoum.

35. "Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis on sepsis-induced coagulopathy in the management of sepsis": Comment from Wada et al.

36. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence.

37. Perioperative Considerations in Management of the Severely Bleeding Coagulopathic Patient.

38. Effect of the time to antivenom administration on recovery from snakebite envenoming-related coagulopathy in French Guiana.

39. Blood Coagulation Disorders in Heart Failure: From Basic Science to Clinical Perspectives.

41. A Case of Multifocal Lymphangioendotheliomatosis With Thrombocytopenia and Changes in Coagulopathy.

42. Clinical features of snake envenomation in South Korea.

43. Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations.

44. Sodium dehydroacetate-induced disorder of coagulation function in broiler chickens and the protective effect afforded by vitamin K.

45. Prothrombinex®-VF in chronic liver disease: Friend or foe?

46. The risk factors for coagulation disorder of chimeric antigen receptor-T cell therapy in patients with hematological tumors: A systematic review and meta-analysis.

47. COVID-19-induced coagulopathy: Experience, achievements, prospects.

48. Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis.

49. Tranexamic acid in pediatric hemorrhagic trauma.

50. Outcomes of 4-factor Prothrombin Complex Concentrate in Patients With Liver Disease and Nonvitamin K Antagonist-Related Coagulopathy: A Retrospective Study.

Catalog

Books, media, physical & digital resources